Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-337-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- September 26, 1988 – October 26, 1988
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Test was conducted according to OECD Test Guideline No. 474, 1983, under GLP Standards, and QA. Chemical identity and purity of the test substance are not reported.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 988
- Report date:
- 1988
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1983
- Deviations:
- yes
- Remarks:
- Limit test dosis: 5000 mg/kg bw
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1984
- Deviations:
- yes
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes
- Remarks:
- Statement of Compliance
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 3-[(diphenoxyphosphoryl)oxy]phenyl diphenyl phosphate
- EC Number:
- 701-337-2
- Cas Number:
- not available
- Molecular formula:
- C30H24O8P2
- IUPAC Name:
- 3-[(diphenoxyphosphoryl)oxy]phenyl diphenyl phosphate
- Details on test material:
- - Name of test material (as cited in study report): CR 733-S
- Physical state: No data
- Lot/batch No.: Confidential
- Stability under test conditions: No data
- Storage condition of test material: At room temperature in the dark
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- Swiss
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga, Sulzfeld, F.R.G.
- Age at study initiation: Approx. 8 weeks
- Weight at study initiation: Males: 28.0 to 31.8 g; Females: 21.7 to 23.4 g
- Assigned to test groups randomly: yes
- Fasting period before study: Feed was withheld overnight before dosing until about 4 hours after administration of the test substance.
- Housing: In groups of 5 in polycarbonate cages. The bedding material, purified saw-dust (Woody Clean), was obtained from the Broekman Institute, Someren, The Netherlands. The cage with females of the corresponding group was placed next to the cage with males.
- Diet: Standard laboratory animal diet (RMH-B, pellet diameter 10 mm), obtained from Hope Farms, Woerden, The Netherlands, ad libitum.
- Water: Tap-water, ad libitum.
- Acclimation period: Combined quarantine/acclimatisation period of 13 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 2
- Humidity (%): 54 - 72
- Air changes (per hr): No data
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: No data
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Concentration of test material in vehicle: (volume) 10 ml/kg bw - Details on exposure:
- No data
- Duration of treatment / exposure:
- 24, 48, and 72 hours (acute)
- Frequency of treatment:
- once (single dose treatment)
- Post exposure period:
- At 24, 48 and 72 hours after dosing of the test substance and the vehicle, and at 48 hours after dosing of the positive control, the animals were sacrificed by cervical dislocation.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
5000 mg/kg bw
Basis:
actual ingested
stomach intubation
- No. of animals per sex per dose:
- 5 males and 5 females per sampling time and treatment group
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Route of administration: orally, gavage
- Doses / concentrations: 50 mg/kg bw
Examinations
- Tissues and cell types examined:
- bone-marrow; micronucleated polychromatic erythrocytes, and ratio polychromatic erythrocytes (PCE)/normochromatic erythrocytes (NCE)
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: In a preliminary study 12 animals (3 males and 3 females per group) were dosed orally with 5000 and 2000 mg/kg bw. None of the animals showed any signs of reaction to treatment. Based on the results of this pilot study 5000 mg/kg bw was selected as an appropriate dose for the Micronucleus Test.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): three different sampling times (24, 48, 72 hours) after oral administration of a single dose (5000 mg/kg).
DETAILS OF SLIDE PREPARATION: A drop of the cell suspension was placed on a slide which was previously cleaned and marked (with the animal number). The preparations were then air-dried and thereafter fixed for 5 min. in 100% methanol and air-dried overnight. Two slides were prepared per animal. The slides were stained 5 min. in May-Grünwald solution. Thereafter slides were rinsed and stained for 25 min in 5% (v/v) Giemsa solution. The preparations were rinsed for 1 min in running tap-water and blotted dry between filter paper. The dry slides were cleared by dipping them in xylol before they were embedded in DePeX and mounted with a coverslip.
METHOD OF ANALYSIS: The number of micronuclei was counted in 1000 polychromatic erythrocytes. The ratio polychromatic to normochromatic erythrocytes was determined by counting and differentiating the first 1000 erythrocytes at the same time. Micronuclei were counted in polychromatic erythrocytes only. - Evaluation criteria:
- A test substance is considered positive in the micronucleus test if:
a) It induces a statistically (P < 0.05) as well as biologically significant increase in the frequencies of micronuclei (at any dose or at any sampling time) in the combined data for both sexes, or in the data for male or female groups separately.
A test substance is considered negative in the micronucleus test if:
a) None of the tested concentrations or sampling times showed a statistically significant (at P < 0.05) increase in the incidence of micronuclei either in the combined data for both sexes or in the data for male or female groups alone. - Statistics:
- The Wilcoxon rank-sum test was used to assess significant differences between the numbers of micronuclei in the treatment and control groups, in which P < 0.05 was used as the lowest level of significance. Averages and standard deviations were calculated.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 2000 and 5000 mg/kg bw
- Clinical signs of toxicity in test animals: None of the animals showed any signs of reaction to treatment.
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): No increase in the frequency of micronuclei was observed.
- Ratio of PCE/NCE (for Micronucleus assay): The animals of the treated groups showed no decrease in the ratio of polychromatic to normochromatic erythrocytes, which reflects a lack of toxic effects of the test substance on the erythropoiesis.
- Appropriateness of dose levels and route: In the preliminary dose range finding study, oral administration of 2000 and 5000 mg kg bw did not cause any effects in male and female mice. 5000 mg kg bw was therefore the regularly limit dose, selected for the main study.
- Statistical evaluation: 5000 mg/kg bw did not show a statistically significant (P < 0.05) increase in the incidence of micronucleated polychromatic erythrocytes from corresponding control group.
Any other information on results incl. tables
Not relevant
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
As no increase in the frequency of micronuclei was observed, it is concluded that CR 733-S can be considered as not mutagenic in this valid Micronucleus Test, under the experimental conditions described in this report. - Executive summary:
CR 733-5 was tested in the Micronucleus Test in mice, according to OECD guideline 474, 1983. Three groups, each comprising 5 males and 5 females, received a single oral dose of 5000 mg/kg bw. Bone marrow was sampled at 24, 48 and 72 hours after dosing. Corresponding vehicle (Corn oil) treated groups served as negative controls. Bone marrow from a positive control group, treated with a single oral dose of Cyclophosphamide (CP) at 50 mg/kg bw, was harvested at 48 hours after dosing only.
The test substance was found to respond negatively in the Micronucleus Test, as no increase in the frequency of micronuclei was observed, whereas the positive control substance (CP) produced a statistically significant increase in the incidence of micronuclei in polychromatic erythrocytes. It is concluded that CR 733-S can be considered as not mutagenic in the Mouse Micronucleus Test, under the experimental conditions described in this report.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.